Home › Atake sa Puso › Michigan
Pag-aaral pangklinika para sa Atake sa Puso sa Michigan
6 pag-aaral para sa Atake sa Puso ang naghahanap ng mga kalahok sa mga site sa Michigan.
Mga Lungsod sa Michigan
Opisyal na teksto ng pag-aaral (English)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Paragon Health, Inc, Kalamazoo
- Michigan Kidney Consultants, PC, Pontiac
- St. Clair Nephrology Research, Roseville
- at 1 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Henry Ford Hospital, Detroit
- AA Medical Research Center, Flint
- Metro Health Univ of MI Health, Wyoming
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Henry Ford Health System, Detroit
- Healthy Heart Cardiology, Grand Rapids
- MyMichigan Medical Center Midland - Clinical Research Department, Midland
- at 2 pa
Nagre-recruitPhase 3
Edad 50 hanggang 105 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Henry Ford Hospital, Detroit
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT06699056Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Henry Ford Health System, Detroit
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04774159Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Midland
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 27, 2026 · NCT06927739Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.